Home » World Health Organization (WHO) » Page 19

World Health Organization (WHO)

CND Day 1 – Agenda item 6(a): Challenges and future work of the CND and the WHO in the review of substances for possible scheduling recommendations

The goal is to assist states in applying the procedures as outlined in the three drug conventions. E/CN.7/2014/10 outlines the relevant provisions of the drug control conventions for scheduling. UNODC – By December 2014, the number of NPS reported by NPS rose to over 540 substances. The global spread of these substances have also increased …

Read more

CND Day 1 – Agenda item 6(b): Change in the scope of control of substances

Commission will identify the notifications in the order they were received. Begin with mephedrone recommended by the UK. Then will look at ketamine recommended by China. Then will look at reocmmendations from the WHO including (a) AH-7921 should be placed in Schedule I of the 1961 Convention; (b) gamma-Butyrolactone (GBL), 1,4-butanediol, 25B-NBOMe (2C-B-NBOMe), 25C-NBOMe (2C-C-NBOMe) …

Read more

The public health approach: Prevention, treatment, risk and harm reduction, recovery, social reintegration and rehabilitation

Chair: Marije Beens. National drug coordinator of Ministry of Health, Welfare and Sport of the Netherland Franz Tratmann, Trimbos Institute Evidence based and best practices are the two keys to improve the quality of intervention. Stablishing effectiveness of investments. You have to translate the clinical evidence into best practices, taking into account cultural values, and personal …

Read more

Public Health Aspects of the World Drug Problem

Organized by the World Health Organization. ON UNGASS website and hard copy available Showed short film.  Introduction by Shekhar Saxena, Chair.  Why is PH approach needed in this area of work.  Drug use is a risk factor associated with poor health and other behavioural risk factors.  Preventable and treatable health conditions.  Ensuring access to controlled …

Read more

UNGASS Special Segment Day 2 – Interactive discussions on demand reduction

Chair. This will include health, HIV, access to essential medicines. The format will include introductory remarks from the chair, as well as 7 minutes presentations from each panellist. Mr. Gilberto Gerra, UNODC. Introductory statement. First question to launch the debate – is it really accepted that young people, people affected by drug use disorder, people …

Read more